Patent ID: 9546131
Date: 2017-01-17
CPC Classifications: A61P,C07B,C07C,C07D

Claim:
1. A method for ameliorating a cancer condition selected from the group consisting of melanoma, breast cancer, pancreatic cancer, multiple myeloma, mantle cell lymphoma, glioma, cancers with low levels of the let-7 microRNA, lung cancer, colon cancer, non-hod kin's 1 mphoma, and T cell acute lympho-blastic leukemia, comprising administering a therapeutically effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof to a subject in need thereof: wherein: n is selected from the group consisting of 0, 1, 2, 3, 4, and 5; each R Z R R R R R R